BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9627177)

  • 21. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation.
    Cotler SJ; Gaur LK; Gretch DR; Wile M; Strong DM; Bronner MP; Carithers RL; Emond MJ; Perkins JD; Nelson KA
    Tissue Antigens; 1998 Nov; 52(5):435-43. PubMed ID: 9864033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBV and HCV infections and acute rejection differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation.
    Minguela A; Miras M; Bermejo J; Sánchez-Bueno F; López-Alvarez MR; Moya-Quiles MR; Muro M; Ontañón J; Garía-Alonso AM; Parrilla P; Alvarez-López MR
    Hum Immunol; 2006 Nov; 67(11):884-93. PubMed ID: 17145368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of liver allograft rejection in man.
    Adams D
    Clin Sci (Lond); 1990 Apr; 78(4):343-50. PubMed ID: 2160351
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of HLA-C on acute rejection in liver transplantation.
    Moya-Quiles MR; Torío A; Muro M; Montes-Ares O; Marin L; Minguela A; Sánchez-Bueno F; Garcia-Alonso AM; Parrilla P; Alvarez-López MR
    Transplant Proc; 2003 Aug; 35(5):1892-3. PubMed ID: 12962836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation.
    Mañez R; White LT; Kusne S; Martin M; Demetris AJ; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):908-9. PubMed ID: 7680170
    [No Abstract]   [Full Text] [Related]  

  • 29. Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.
    Uchiyama H; Kayashima H; Matono R; Shirabe K; Yoshizumi T; Ikegami T; Soejima Y; Matsuura T; Taguchi T; Maehara Y
    Clin Transplant; 2012; 26(5):E522-9. PubMed ID: 23061761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes.
    Araújo MB; Leonardi LS; Boin IF; Leonardi MI; Magna LA; Donadi EA; Kraemer MH
    Transplant Proc; 2004 May; 36(4):953-5. PubMed ID: 15194331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.
    Aldridge RW; Mattes FM; Rolando N; Rolles K; Smith C; Shirling G; Atkinson C; Burroughs AK; Milne RS; Emery VC; Griffiths PD
    Transpl Infect Dis; 2015 Feb; 17(1):25-32. PubMed ID: 25572799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic liver allograft dysfunction.
    Desai M; Neuberger J
    Transplant Proc; 2009 Mar; 41(2):773-6. PubMed ID: 19328977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
    Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
    J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of INF-gamma, TNF-alpha and dendritic cells to predict hepatitis C virus recurrence in liver transplant patients.
    Ocaña L; Cos J; Quer J; Bilbao I; Palou E; Parra R; Sauleda S; Esteban JI; Guàrdia J; Massuet LI; Margarit C
    Transplant Proc; 2005 Nov; 37(9):3951-6. PubMed ID: 16386594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.
    Créput C; Durrbach A; Menier C; Guettier C; Samuel D; Dausset J; Charpentier B; Carosella ED; Rouas-Freiss N
    J Hepatol; 2003 Oct; 39(4):587-94. PubMed ID: 12971970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1182-8. PubMed ID: 16343070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC antigen expression in human liver grafts: its role in rejection.
    Snover DC
    Hepatology; 1990 Apr; 11(4):704-6. PubMed ID: 2328962
    [No Abstract]   [Full Text] [Related]  

  • 39. [Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses].
    Hopf U; Neuhaus P; König V; Bauditz J; Küther S; Schmidt CA; Steffen R; Blumhardt G; Bechstein WO; Neuhaus R
    Z Arztl Fortbild (Jena); 1992 Sep; 86(17):861-8. PubMed ID: 1413903
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of ABO and Lewis blood group antigens in donor-recipient compatibility of corneal transplantation rejection.
    Roy R; Des Marchais B; Bazin R; Boisjoly HM; Dubé I; Laughrea PA
    Ophthalmology; 1997 Mar; 104(3):508-12. PubMed ID: 9082281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.